645 related articles for article (PubMed ID: 12224504)
1. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
Johnson DC; Hegde NR
Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
[TBL] [Abstract][Full Text] [Related]
3. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.
Chevalier MS; Daniels GM; Johnson DC
J Virol; 2002 Aug; 76(16):8265-75. PubMed ID: 12134032
[TBL] [Abstract][Full Text] [Related]
4. Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties.
Chevalier MS; Johnson DC
J Virol; 2003 Apr; 77(8):4731-8. PubMed ID: 12663780
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells.
Tomazin R; Boname J; Hegde NR; Lewinsohn DM; Altschuler Y; Jones TR; Cresswell P; Nelson JA; Riddell SR; Johnson DC
Nat Med; 1999 Sep; 5(9):1039-43. PubMed ID: 10470081
[TBL] [Abstract][Full Text] [Related]
6. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4
Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T
Front Immunol; 2018; 9():1129. PubMed ID: 29887865
[TBL] [Abstract][Full Text] [Related]
7. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.
Pande NT; Powers C; Ahn K; Früh K
J Virol; 2005 May; 79(9):5786-98. PubMed ID: 15827193
[TBL] [Abstract][Full Text] [Related]
8. Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells.
Hegde NR; Johnson DC
J Virol; 2003 Sep; 77(17):9287-94. PubMed ID: 12915544
[TBL] [Abstract][Full Text] [Related]
9. MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance.
Benz C; Hengel H
Virus Genes; 2000; 21(1-2):39-47. PubMed ID: 11022788
[TBL] [Abstract][Full Text] [Related]
10. Signal peptide-dependent inhibition of MHC class I heavy chain translation by rhesus cytomegalovirus.
Powers CJ; Früh K
PLoS Pathog; 2008 Oct; 4(10):e1000150. PubMed ID: 18833297
[TBL] [Abstract][Full Text] [Related]
11. Human cytomegalovirus US3 modulates destruction of MHC class I molecules.
Noriega VM; Hesse J; Gardner TJ; Besold K; Plachter B; Tortorella D
Mol Immunol; 2012 Jun; 51(2):245-53. PubMed ID: 22497807
[TBL] [Abstract][Full Text] [Related]
12. Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.
Sandhu PK; Buchkovich NJ
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915281
[TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus: host immune modulation by the viral US3 gene.
Liu Z; Winkler M; Biegalke B
Int J Biochem Cell Biol; 2009 Mar; 41(3):503-6. PubMed ID: 18992841
[TBL] [Abstract][Full Text] [Related]
14. The HCMV gene products US2 and US11 target MHC class I molecules for degradation in the cytosol.
van der Wal FJ; Kikkert M; Wiertz E
Curr Top Microbiol Immunol; 2002; 269():37-55. PubMed ID: 12224515
[TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus-encoded immune modulators partner to downregulate major histocompatibility complex class I molecules.
Noriega VM; Tortorella D
J Virol; 2009 Feb; 83(3):1359-67. PubMed ID: 19004944
[TBL] [Abstract][Full Text] [Related]
16. Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection.
Terauchi M; Koi H; Hayano C; Toyama-Sorimachi N; Karasuyama H; Yamanashi Y; Aso T; Shirakata M
J Virol; 2003 Aug; 77(15):8187-95. PubMed ID: 12857887
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread.
Huber MT; Tomazin R; Wisner T; Boname J; Johnson DC
J Virol; 2002 Jun; 76(11):5748-58. PubMed ID: 11992003
[TBL] [Abstract][Full Text] [Related]
18. Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules.
Sinzger C; Eberhardt K; Cavignac Y; Weinstock C; Kessler T; Jahn G; Davignon JL
J Gen Virol; 2006 Jul; 87(Pt 7):1853-1862. PubMed ID: 16760387
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells.
Rehm A; Engelsberg A; Tortorella D; Körner IJ; Lehmann I; Ploegh HL; Höpken UE
J Virol; 2002 May; 76(10):5043-50. PubMed ID: 11967320
[TBL] [Abstract][Full Text] [Related]
20. The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products.
Park B; Oh H; Lee S; Song Y; Shin J; Sung YC; Hwang SY; Ahn K
J Immunol; 2002 Apr; 168(7):3464-9. PubMed ID: 11907106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
